Drug Trial Radar · NCT00166244
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
Last checked: Nov 19, 2026Latest source record: Feb 12, 2009 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
901
Actual
Start
May 2003
Primary completion
Mar 2005
Study completion Apr 2006
Sponsor
- Lead sponsor
- Erasmus Medical CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Hoffmann-La Roche
- First posted
- Sep 14, 2005
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Determine the value of a clinically feasible strategy of therapeutic drug monitoring compared with fixed dosing in de novo MMF treated renal transplant recipients with respect to the incidence of treatment failure.
Conditions
- De Novo Renal Transplant Recipient.
Interventions
Mycophenolate MofetilDrug
1 g for adult patients and 300 mg/m2 for paediatric patients. Fixed dose arm: 1 g twice a day (bid) for adults and 600mg/m2 bid for paediatric patients. Concentration controlled arm: initial dose will be 1 g bid for adults and 600mg/m2 bid for paediatric patients. Abbreviated AUCs (taken at timepoints: 0, 30min and 120min in fasted patients) on Days 3 and 10, Week 4, Months 3, 6 and 12 will be performed to determine mycophenolic acid levels in plasma.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Treatment failure including the occurrence of the first one of any of the following: biopsy-proven acute rejection, graft loss, death or discontinuation of MMF therapy during the first 12 months following transplantation.Time frame: 12 Months
Locations
67 sites in 19 countries. Site status is shown where the registry gives one.
John Hunter Hospital
New Lambton, New South Wales, Australia
Princess Alexandra Hospital
Brisbane, Queensland, Australia
Monash Medical Centre
Clayton, Victoria, Australia
St Vincent's Hospital
Melbourne, Victoria, Australia
Royal Melbourne Hospital
Parkville, Victoria, Australia
Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia
Royal Perth Hospital
Perth, Western Australia, Australia
Med. Univ. Klinik
Graz, Austria
AKH Wien
Vienna, Austria
University Hospitals Leuven
Leuven, Belgium
Hospital do Rim e Hipertensao
São Paulo, Brazil
Vancouver General Hospital
Vancouver, British Columbia, Canada
Ruijin Hospital
Shanghai, Shanghai Municipality, China
West China Hospital of Sichuan University
Chengdu, Sichuan, China
Odense University Hospital
Odense, Denmark
Surgical Clinic Of Tartu University Clinics
Tartu, Estonia
Hopital Pellegrin, C.H.R.de Bordeaux
Bordeaux, France
Hospital du Bocage
Dijon, France
CHU de Grenoble
Grenoble, France
CHU Kremlin Bicêtre
Le Kremlin-Bicêtre, France
Hopital Calmette
Lille, France
Hopital Jeanne de Flandres
Lille, France
Centre Hospitalier Regional Universitaire
Limoges, France
CHU Hotel Dieu
Nantes, France
Hopital Necker
Paris, France
Hopital Tenon
Paris, France
Centre Hospitalier Lyon Sud
Pierre-Bénite, France
Hopital Foch
Suresnes, France
CHU Purpan
Toulouse, France
CHU Rangueil
Toulouse, France
CHU de Nancy-Brabois
Vandœuvre-lès-Nancy, France
Universitatsklinikum Charite
Berlin, Germany
Stadt Kliniken Koln
Cologne, Germany
Chirurgische Universitätsklinik
Freiburg im Breisgau, Germany
Universitatsklinikum Heidelberg
Heidelberg, Germany
University of Heidelberg
Heidelberg, Germany
University Hospital Wurzburg
Würzburg, Germany
Vilnius University Hospital
Vilnius, Lithuania
Leids Universitair Medisch Centrum
Leiden, Netherlands
Erasmus Medical Center Rotterdam
Rotterdam, Netherlands
Showing 40 of 67 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.